๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical investigation in Duchenne Dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection

โœ Scribed by Dr. Robert C. Griggs; Dr. Jerry R. Mendell; Dr. Michael H. Brooke; Dr. Gerald M. Fenichel; Dr. J. Phillip Miller; Dr. Michael Province; Dr. Richard T. Moxley III; Ms. Donna Huntzinger; Dr. Arthur Vaughn; Ms. Melinda Cohen; Dr. P. Michael Conneally; Dr. Phillip Bach


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
615 KB
Volume
8
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Duchenne muscular dystrophy carrier dete
โœ Percy, Maire E. ;Andrews, David F. ;Thompson, Margaret W. ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 710 KB

## Abstract In the absence of an unambiguous test for identifying Duchenne muscular dystrophy (DMD) heterozygotes, methods are needed for combination of the results of individually equivocal tests as effectively and rationally as possible. We used logistic discrimination to assess the effectiveness

Evaluation of carrier detection of Duche
โœ Heath, R. ;Carter, N. D. ;Jeffery, S. ;Edwards, R. J. ;Watts, D. C. ;Watts, R. L ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 308 KB ๐Ÿ‘ 2 views

Carbonic anhydrase III (CAIII) and creatine kinase (CK) were measured in plasma samples from a series of females at-risk as carriers of Duchenne muscular dystrophy and compared with control groups. Both plasma CAIII and CK levels were raised in a proportion of carriers. Although measurement of CAIII